What is the appropriate workup and management for an elevated parathyroid hormone (PTH) level identified in a primary‑care setting?

Elevated PTH in Primary Care: Workup and Management

When you encounter an elevated PTH in primary care, first measure serum calcium, 25-OH vitamin D, and assess renal function to differentiate primary hyperparathyroidism from secondary causes—this single step determines your entire management pathway.

Initial Diagnostic Approach

Essential Laboratory Workup

When PTH is elevated, immediately obtain:

• Serum calcium (albumin-corrected or ionized)
• 25-OH vitamin D levels
• Serum creatinine/eGFR
• Serum phosphate
• 24-hour urine calcium (or spot urine calcium/creatinine ratio)

The pattern of these results determines the diagnosis 1:

Diagnostic Algorithm

If PTH is elevated WITH hypercalcemia:

• Primary hyperparathyroidism (PHPT) is the diagnosis when PTH is inappropriately normal or elevated in the setting of hypercalcemia 2, 1
• Confirm with elevated or normal fractional calcium excretion (>2%) to exclude familial hypocalciuric hypercalcemia 2
• Proceed directly to target organ assessment (see below)

If PTH is elevated WITH normal calcium (normocalcemic PHPT):

This requires more rigorous evaluation before accepting the diagnosis 1:

1. First, exclude secondary hyperparathyroidism:

   • Correct vitamin D deficiency (aim for 25-OH vitamin D >20 ng/mL or >50 nmol/L) 3
   • Maintain normal vitamin D levels for at least 6 months before diagnosing normocalcemic PHPT 2, 1
   • Ensure adequate dietary calcium intake
   • Assess for chronic kidney disease
   • Check for medications causing hypocalciuria

2. Confirm persistent elevation:

   • Repeat PTH measurement after 3-6 months with corrected vitamin D status 1
   • Consider oral calcium loading test if available to differentiate from secondary hyperparathyroidism 2, 1

If PTH is elevated WITH hypocalcemia:

• This indicates secondary hyperparathyroidism
• Common causes: vitamin D deficiency, chronic kidney disease, malabsorption, medications
• Treat the underlying cause rather than the PTH elevation itself

Target Organ Assessment for Confirmed PHPT

Once PHPT is diagnosed, systematically evaluate for complications 2:

Mandatory Assessments:

• Renal:

  • eGFR/creatinine
  • 24-hour urine calcium (assess for hypercalciuria and stone risk)
  • Renal ultrasound or CT (screen for nephrolithiasis, nephrocalcinosis)

• Skeletal:

  • Bone mineral density (DXA scan at lumbar spine, hip, and distal 1/3 radius)
  • Vertebral imaging if height loss or back pain present

• Biochemical:

  • Serum calcium (severity assessment)
  • Serum phosphate (typically low-normal in PHPT)

Management Decision: Surgery vs. Observation

Indications for Parathyroidectomy 4:

Surgery is indicated if ANY of the following are present:

1. Symptomatic disease:

   • Nephrolithiasis or nephrocalcinosis
   • Osteoporotic fracture
   • Symptomatic hypercalcemia (fatigue, cognitive impairment, mood disturbances)

2. Biochemical criteria:

   • Serum calcium >1 mg/dL above upper limit of normal
   • 24-hour urine calcium >400 mg/day

3. Skeletal criteria:

   • T-score ≤-2.5 at any site (lumbar spine, hip, or distal radius)
   • Vertebral fracture on imaging

4. Renal criteria:

   • eGFR <60 mL/min/1.73m²
   • Presence of nephrolithiasis or nephrocalcinosis

5. Age <50 years (revised criterion recognizing long-term disease burden) 4

Medical Management for Non-Surgical Candidates

For patients who don't meet surgical criteria, refuse surgery, or have contraindications 5, 6:

• Monitoring protocol:

  • Serum calcium every 6-12 months
  • Annual bone density assessment
  • Annual renal function and imaging
  • Maintain 25-OH vitamin D >20 ng/mL 3

• Pharmacologic options (none are curative):

  • Bisphosphonates: For osteoporosis management (improves BMD but doesn't address hypercalcemia)
  • Calcimimetics (cinacalcet): Lowers serum calcium but use with caution—monitor for hypocalcemia and QT prolongation 3, 7
  • Adequate hydration: Prevents nephrolithiasis

Critical Pitfalls to Avoid

1. Don't diagnose normocalcemic PHPT without correcting vitamin D deficiency first—this is the most common error. Vitamin D insufficiency causes secondary hyperparathyroidism that mimics normocalcemic PHPT 1.

2. Don't assume asymptomatic means benign—80-90% of PHPT patients are "asymptomatic" but may have subtle cognitive, mood, or fatigue symptoms that improve after surgery 2, 5.

3. Don't order parathyroid imaging before confirming surgical candidacy—imaging (ultrasound, sestamibi, 4D-CT, or PET) is only useful for surgical planning, not diagnosis 2.

4. Be aware of PTH assay variability—different generations of PTH assays measure different fragments. For PHPT diagnosis, the absolute value matters less than the inappropriateness relative to calcium 8.

5. Don't forget genetic screening—up to 10% of PHPT is hereditary (MEN1, MEN2A, hyperparathyroidism-jaw tumor syndrome). Consider genetic testing in patients <40 years, with family history, or with multiglandular disease 9.

When to Refer

Refer to endocrinology:

• All confirmed cases of PHPT for treatment planning 10
• Normocalcemic PHPT after excluding secondary causes
• Uncertainty in diagnosis
• Need for medical management guidance

Refer to endocrine surgery:

• All patients meeting surgical criteria
• Patients desiring definitive treatment even without absolute indications